Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
NCT01551173
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
436
Enrollment
INDUSTRY
Sponsor class
Conditions
Lipid Metabolism Disorders
Interventions
DRUG:
Fluvastatin sodium
Sponsor
Novartis Pharmaceuticals